Bill allowing state lawyers access to doctors database of controlled substance users signed into Florida law

JIM TURNER | June 26, 2019

article image
A measure that would allow attorneys for the state to have access to a prescription-drug database as they pursue a lawsuit against the pharmaceutical industry over the opioid epidemic was among 10 bills signed Monday by Gov. Ron DeSantis. The signings nine were announced by the governor’s office Tuesday morning came less than a week before all 10 of the bills will take effect July 1. The drug database law (HB 1253) was a priority during this year’s legislative session of Attorney General Ashley Moody, who considered access to the records a critical weapon in the state’s lawsuit against the pharmaceutical industry.

Spotlight

Lifescience Dynamics Limited

Founded in 2004, Lifescience Dynamics is a decision support firm helping life science companies (pharmaceutical, biotechnology, diagnostics and medical devices) with strategic insight and foresight to improve their assumptions, enabling them to make better decisions. Typical projects undertaken aim to address clients’ business issues and challenges to maximise the full commercial potential of their assets.

OTHER ARTICLES

How pharma can continue engaging HCPs in a world gripped by COVID-19

Article | April 10, 2020

Medscape is the leading source of clinical news, health information, and point-of-care tools for healthcare professionals. Medscape offers specialists, primary care physicians, and other health professionals the most robust and integrated medical information and educational tools. Medscape Education (medscape.org) is the leading destination for continuous professional development, consisting of more than 30 specialty-focused destinations offering thousands of free CME and CE courses and other educational programmes for physicians, nurses, and other healthcare professionals. Both Medscape and Medscape Education are part of WebMD Health Corp., an Internet Brands company. Face-to-face interactions between pharma and physicians have essentially ceased overnight during the COVID-19 pandemic, but that doesn’t mean HCPs have stopped looking for new medical information.

Read More

How AI and Big Data Will Disrupt Pharma’s Regulatory Compliance Standards

Article | April 10, 2020

The industry as we know it is changing. Pharmaceutical and life sciences companies across the globe are experiencing more pressure than ever to keep up with increased regulatory standards while moving at a pace that requires them to innovate in order to remain competitive. With more real-time automation and the steady increase in AI and Big Data sweeping the landscape, what used to be a slow-to-change and risk-averse industry is now expected to see a significant shift towards newer technology that focus on heightened regulatory standards. Here’s how your company can get ahead of what industry experts are calling, Pharma

Read More

Clinical Supply Availability & Speed to Study Start-Up

Article | April 10, 2020

If you’re part of a clinical study team racing a new product to commercialization, you likely live by these two simple rules: time is money, and the first one to market wins. But just because it’s simple doesn’t mean it’s easy. That ticking clock is background noise to the responsibilities of regulations, study protocols, supply chains, and patient recruitment — all the details that must be worked out before a study can even begin. The pressure is always there. The longer it takes for a study to start, the longer it takes to complete.

Read More

The Future of Pharma Beyond Blockbusters

Article | April 10, 2020

We’ve all heard the saying “treat the patient, not the disease”, and this couldn’t be truer in today’s ever-changing pharmaceutical landscape. We are living in a time of revolution – advancements in genomics and technology are improving our ability to develop precise drugs and targeted therapies, rather than focusing on a one size fits all approach. Each individual’s genetic makeup is slightly different from everyone else’s,

Read More

Spotlight

Lifescience Dynamics Limited

Founded in 2004, Lifescience Dynamics is a decision support firm helping life science companies (pharmaceutical, biotechnology, diagnostics and medical devices) with strategic insight and foresight to improve their assumptions, enabling them to make better decisions. Typical projects undertaken aim to address clients’ business issues and challenges to maximise the full commercial potential of their assets.

Events